Terminal Conditions, End of Life Clinical Trial
— BEACON IIOfficial title:
Evaluation of Methods for Implementation of a Comfort Care Order Set
Verified date | July 2023 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The overarching goal of this research program is to improve the quality of end-of-life care provided to Veterans dying in VA Medical Centers (VAMCs), by transferring the best practices of home hospice and palliative care for the last days and hours of life into the inpatient setting. This trial will examine two methods of delivering a Comfort Care Education Intervention utilizing the established infrastructure of VA Palliative Care Consult Teams (PCCT): a Basic Implementation Approach using a teleconference to review educational materials and activate PCCTs to educate other providers, and an Enhanced Implementation Approach utilizing in-person, train-the-"champion" workshops to prepare PCCT members to be leaders and trainers at their home sites. Findings will provide a robust evaluation of the implementation process, and will be used to refine the Comfort Care Education Intervention and implementation strategies in preparation for nationwide dissemination of best practices for end-of-life care within the VA Healthcare System.
Status | Completed |
Enrollment | 134 |
Est. completion date | January 31, 2020 |
Est. primary completion date | April 30, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: To be eligible, each provider had to be a member of a VA palliative care consult team (PCCT) Exclusion Criteria: VAMCs were excluded if the facility scored in the top 10th percentile or lowest 10th percentile on PROMISE after-death survey; if they had no prescribing provider on the PCCT team; or if there were fewer than 30 deaths in VAMC during the reporting period |
Country | Name | City | State |
---|---|---|---|
United States | Birmingham VA Medical Center, Birmingham, AL | Birmingham | Alabama |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Presence of an Active Opioid Order at Time of Death | presence of an active opioid order at time of death in Veteran's medical record | at time of death for veterans who died in the 9 months following the intervention period | |
Secondary | Presence of an Order for Benzodiazepine Medication | presence of an order for benzodiazepine medication in the last 7 days of life | last 7 days of life for veterans who died in the 9 months following the intervention period | |
Secondary | Presence of a Do-not-resuscitate Order | presence of a do-not-resuscitate order in the last 7 days of life | last 7 days of life for veterans who died in the 9 months following the intervention period | |
Secondary | Presence of a Palliative Care Consult Order | presence of a palliative care consult order in the last 7 days of life | last 7 days of life for veterans who died in the 9 months following the intervention period | |
Secondary | Location of Death | death in intensive care unit | in the 9 months following the intervention period | |
Secondary | Presence of a Nasogastric Tube | presence of a nasogastric tube at time of death | in the 9 months following the intervention period | |
Secondary | Presence of an Intravenous Line | presence of an intravenous line at time of death | in the 9 months following the intervention period | |
Secondary | Presence of Restraints | presence of restraints at time of death | in the 9 months following the intervention period | |
Secondary | Presence of a Pastoral Care Visit | presence of a pastoral care visit in the last 7 days of life | last 7 days of life for veterans who died in the 9 months following the intervention period |